<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font28 { font-size : 28; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">Typhi </span>
   <span class="font30">fever </span>
   <span class="font28">Salmonella </span>
   <span class="font28">typhoid </span>
   <span class="font25">azithromycin </span>
   <span class="font25">days </span>
   <span class="font24">Azithromycin </span>
   <span class="font22">resistance </span>
   <span class="font22">mg/kg </span>
   <span class="font22">treatment </span>
   <span class="font21">clinical </span>
   <span class="font20">Gatifloxacin </span>
   <span class="font20">Ofloxacin </span>
   <span class="font19">blood </span>
   <span class="font19">enterica </span>
   <span class="font18">susceptibility </span>
   <span class="font18">ofloxacin </span>
   <span class="font17">Infect. </span>
   <span class="font17">day) </span>
   <span class="font17">failure: </span>
   <span class="font17">antimicrobial </span>
   <span class="font17">isolates </span>
   <span class="font17">therapy </span>
   <span class="font16">ciprofloxacin </span>
   <span class="font16">{border-style </span>
   <span class="font16">Clinical </span>
   <span class="font16">Dis. </span>
   <span class="font16">India </span>
   <span class="font16">MDR </span>
   <span class="font16">combination </span>
   <span class="font16">rates </span>
   <span class="font16">reported </span>
   <span class="font16">treating </span>
   <span class="font16">uncomplicated </span>
   <span class="font16">MIC </span>
   <span class="font16">day </span>
   <span class="font16">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">Clin. </span>
   <span class="font15">study </span>
   <span class="font15">Indian </span>
   <span class="font15">Microbiol. </span>
   <span class="font15">culture </span>
   <span class="font15">enteric </span>
   <span class="font15">patients </span>
   <span class="font15">However, </span>
   <span class="font15">Med. </span>
   <span class="font15">use </span>
   <span class="font14">Ceftriaxone </span>
   <span class="font14">cephalosporin </span>
   <span class="font14">fluoroquinolone </span>
   <span class="font14">fluoroquinolones </span>
   <span class="font14">cases </span>
   <span class="font14">failure </span>
   <span class="font14">management </span>
   <span class="font14">serovar </span>
   <span class="font14">ceftriaxone </span>
   <span class="font14">chloramphenicol </span>
   <span class="font14">dose </span>
   <span class="font14">reduced </span>
   <span class="font14">trials </span>
   <span class="font13">Parry </span>
   <span class="font13">rate </span>
   <span class="font13">μg/ml </span>
   <span class="font13">Antimicrob. </span>
   <span class="font13">Cefixime </span>
   <span class="font13">Chloramphenicol </span>
   <span class="font13">Paratyphi </span>
   <span class="font13">Typhi. </span>
   <span class="font13">Typhoid </span>
   <span class="font13">increased </span>
   <span class="font13">relapse </span>
   <span class="font13">resistant </span>
   <span class="font13">trial </span>
   <span class="font13">typhoidal </span>
   <span class="font13">Antimicrobial </span>
   <span class="font13">Microbiological </span>
   <span class="font13">cefixime </span>
   <span class="font13">controlled </span>
   <span class="font13">developing </span>
   <span class="font13">diagnosis </span>
   <span class="font13">duration </span>
   <span class="font13">fever. </span>
   <span class="font12">-day </span>
   <span class="font12">Agents </span>
   <span class="font12">Asia </span>
   <span class="font12">Chemother. </span>
   <span class="font12">Randomized </span>
   <span class="font12">Table </span>
   <span class="font12">Trop. </span>
   <span class="font12">activity </span>
   <span class="font12">antibiotic </span>
   <span class="font12">bla </span>
   <span class="font12">cephalosporins, </span>
   <span class="font12">choice </span>
   <span class="font12">drug </span>
   <span class="font12">group: </span>
   <span class="font12">laboratory </span>
   <span class="font12">nalidixic </span>
   <span class="font12">px; </span>
   <span class="font12">seen </span>
   <span class="font12">strains </span>
   <span class="font12">studies </span>
   <span class="font12">susceptible </span>
   <span class="font12">third-generation </span>
   <span class="font12">versus </span>
   <span class="font12">{font-family </span>
   <span class="font12">DCS </span>
   <span class="font12">Typhi, </span>
   <span class="font12">cephalosporins </span>
   <span class="font12">defervescence </span>
   <span class="font12">font-size </span>
   <span class="font12">gatifloxacin </span>
   <span class="font12">infection </span>
   <span class="font12">poor </span>
   <span class="font12">significant </span>
   <span class="font12">time </span>
   <span class="font12">vitro </span>
   <span class="font12">Describes </span>
   <span class="font12">India, </span>
   <span class="font12">India. </span>
   <span class="font12">Laboratory </span>
   <span class="font12">Sharma </span>
   <span class="font12">Standards </span>
   <span class="font12">alternative </span>
   <span class="font12">antibiotics </span>
   <span class="font12">available </span>
   <span class="font12">burden </span>
   <span class="font12">countries. </span>
   <span class="font12">double; </span>
   <span class="font12">efficacy </span>
   <span class="font12">emergence </span>
   <span class="font12">leaf </span>
   <span class="font12">monotherapy </span>
   <span class="font12">open </span>
   <span class="font12">oral </span>
   <span class="font12">preferred </span>
   <span class="font12">review </span>
   <span class="font12">standard </span>
   <span class="font12">treated </span>
   <span class="font12">used </span>
   <span class="font11">Arjyal </span>
   <span class="font11">Balaji </span>
   <span class="font11">Basnyat </span>
   <span class="font11">CLSI </span>
   <span class="font11">Enzymatic </span>
   <span class="font11">Future </span>
   <span class="font11">Institute </span>
   <span class="font11">New </span>
   <span class="font11">Prospective </span>
   <span class="font11">Similarly, </span>
   <span class="font11">South </span>
   <span class="font11">ampicillin, </span>
   <span class="font11">analysis </span>
   <span class="font11">antimicrobials </span>
   <span class="font11">azithromycin, </span>
   <span class="font11">bacterial </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">breakpoints </span>
   <span class="font11">combinations </span>
   <span class="font11">cotrimoxazole </span>
   <span class="font11">decreased </span>
   <span class="font11">demonstrated </span>
   <span class="font11">detection </span>
   <span class="font11">drugs </span>
   <span class="font11">effective </span>
   <span class="font11">extract </span>
   <span class="font11">fever: </span>
   <span class="font11">high </span>
   <span class="font11">higher </span>
   <span class="font11">hydrolysis </span>
   <span class="font11">infection. </span>
   <span class="font11">longer </span>
   <span class="font11">manuscript. </span>
   <span class="font11">microbiological </span>
   <span class="font11">multidrug-resistant </span>
   <span class="font11">plasmid-mediated </span>
   <span class="font11">plus </span>
   <span class="font11">prescribed </span>
   <span class="font11">randomized </span>
   <span class="font11">recent </span>
   <span class="font11">recommended </span>
   <span class="font11">respectively </span>
   <span class="font11">response </span>
   <span class="font11">rise </span>
   <span class="font11">safety </span>
   <span class="font11">sensitivity </span>
   <span class="font11">showed </span>
   <span class="font11">solid; </span>
   <span class="font11">specificity </span>
   <span class="font11">spectrum </span>
   <span class="font11">tests </span>
   <span class="font11">therapy, </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">.–. </span>
   <span class="font11">Bakthavatchalam </span>
   <span class="font11">Cephalosporins </span>
   <span class="font11">East </span>
   <span class="font11">FDCs </span>
   <span class="font11">Fluoroquinolones </span>
   <span class="font11">Furthermore, </span>
   <span class="font11">Int. </span>
   <span class="font11">Negl. </span>
   <span class="font11">Ofloxacin/azithromycin </span>
   <span class="font11">RCT/Nepal </span>
   <span class="font11">Res. </span>
   <span class="font11">Treatment </span>
   <span class="font11">acid </span>
   <span class="font11">acid-resistant </span>
   <span class="font11">associated </span>
   <span class="font11">based </span>
   <span class="font11">better </span>
   <span class="font11">bold </span>
   <span class="font11">carriage </span>
   <span class="font11">case </span>
   <span class="font11">cefixime–azithromycin </span>
   <span class="font11">ceftriaxone–azithromycin </span>
   <span class="font11">children </span>
   <span class="font11">class </span>
   <span class="font11">commonly </span>
   <span class="font11">compared </span>
   <span class="font11">comparison </span>
   <span class="font11">concern </span>
   <span class="font11">confirmed </span>
   <span class="font11">containing </span>
   <span class="font11">control </span>
   <span class="font11">countries </span>
   <span class="font11">courier; </span>
   <span class="font11">cultures </span>
   <span class="font11">cure </span>
   <span class="font11">daily </span>
   <span class="font11">doses </span>
   <span class="font11">effect </span>
   <span class="font11">em; </span>
   <span class="font11">individual </span>
   <span class="font11">intracellular </span>
   <span class="font11">issues </span>
   <span class="font11">limited </span>
   <span class="font11">media </span>
   <span class="font11">monitoring </span>
   <span class="font11">observed </span>
   <span class="font11">open-label, </span>
   <span class="font11">options </span>
   <span class="font11">pefloxacin </span>
   <span class="font11">practice </span>
   <span class="font11">profile </span>
   <span class="font11">pt;} </span>
   <span class="font11">quinolone </span>
   <span class="font11">sustained </span>
   <span class="font11">testing </span>
   <span class="font11">therapeutic </span>
   <span class="font11">this, </span>
   <span class="font11">typhi </span>
   <span class="font11">usage </span>
   <span class="font11">using </span>
  </p>
 </body>
</html>
